Charting a Path for the Integration of Immunotherapy in the Treatment of Multiple Myeloma OncLive, 11 Mar 2022 In Partnership With: Fenghuang Zhan, MD, PhD, and John D. Shaughnessy, Jr, PhD, discuss the need for a paradigm shift in the…